BioSpace News Archive

Business

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,312.50 and $42,800.00, respectively.

June 29, 2018
·
2 min read
FDA

FDA approves novel device for treating breathing difficulty from severe emphysema

The U.S. Food and Drug Administration (FDA) today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.

June 29, 2018
·
4 min read
Business

As Amazon enters drug distribution, patients and physicians are hopeful for healthcare disruption

Amazon’s announced acquisition of PillPack gives the tech giant a vehicle for disrupting the U.S. drug distribution market - and may come with a beneficial side-effect for pharma.

June 29, 2018
·
3 min read
Business

Health Minister Ginette Petitpas Taylor announces two new members of the Patented Medicine Prices Review Board

The Government of Canada is committed to open, transparent and merit-based selection processes for Governor in Council appointments.

June 29, 2018
·
2 min read
FDA

FDA Approves Zephyr Endobronchial Valve for Treating Severe Emphysema

Pulmonx® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System.

June 29, 2018
·
4 min read
MEDISCA Signs Exclusive Distribution Agreement for FLAVORx Flavours in the Canadian Market

Customized Medication Flavouring Improves Patient Compliance

June 29, 2018
·
2 min read
Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a definitive agreement to sell its rights related to Prialt® (ziconotide) intrathecal infusion to TerSera Therapeutics LLC (TerSera).

June 29, 2018
·
5 min read
Job Trends

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL Syringe Due to Mislabeling

Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level.

June 29, 2018
·
3 min read
Drug Development

Spectrum Pharmaceuticals Presents ADVANCE Phase 3 ROLONTIS® (eflapegrastim) Data at MASCC 2018 and Announces the Phase 3 RECOVER Study Met the Primary Endpoint

ADVANCE, first Phase 3 study, met the non-inferiority of ROLONTIS to pegfilgrastim endpoint in the Duration of Severe Neutropenia (DSN) across all 4 cycles (all p<0.0001)

June 29, 2018
·
8 min read
BioMidwest

Rockwell Medical Provides Investor Update

Rockwell Medical, Inc. provided an update to its investors.

June 29, 2018
·
6 min read